Bright Green Corporation

Bright Green Corporation is a producer and exporter of legal cannabis, cannabis extracts, and tetrahydrocannabinol in the United States. Its products support research, manufacturing, export activities, and the production of medical cannabis products and preparations. The company holds DEA authorization for cultivating and manufacturing Schedule I and II plant-based controlled substances, positioning it as a domestic supplier of raw materials for cannabinoid, psychedelic, and opioid-based drugs used in pharmaceutical applications. Incorporated in 2019 and headquartered in Grants, New Mexico, Bright Green Corporation operates a facility designed for compliance with federal and state regulations for controlled substance production. It focuses on plant-based active pharmaceutical ingredients (APIs) and has pursued partnerships to supply DEA-approved extracts for cGMP pharmaceutical-grade production. Currently under Chapter 11 reorganization filed in February 2025, the company maintains its core operations in the healthcare sector, specifically drug manufacturing for specialty and generic medicinal chemicals and botanical products.